Related Experiment Video
Updated: Jul 3, 2026

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012
Visceral leishmanisis in paediatrics: a study of 367 cases in southwest Iran
Moslehi Mohammad Ashkan1, Kadivar Mohammad Rahim
1Department of Pediatrics, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran. moslehim@sums.ac.ir
Insights
Kala-azar, or visceral leishmaniasis, is common in Iranian children. Glucantim therapy is effective, but jaundice indicates a poor prognosis for visceral leishmaniasis patients.
Area of Science:
- Tropical medicine
- Infectious diseases
- Parasitology
Background:
- Visceral leishmaniasis (Kala-azar) is a significant public health concern in southern Iran.
- This study retrospectively analyzes cases of visceral leishmaniasis in infants and children in Fars Province.
Observation:
- Seasonal variations in VL cases were noted, with peaks in late winter and spring.
- Predominant clinical signs included chronic fever, pallor, weight loss, abdominal distention, and hepatosplenomegaly.
- Common laboratory findings were anemia, leukopenia, thrombocytopenia, hypoalbuminemia, and hypergammaglobulinemia.
Findings:
- All patients tested positive via immunofluorescence antibody test and Leishmania donovani confirmation (bone marrow smear/culture).
- Glucantim therapy achieved a high cure rate (96.7%), with a relapse rate of 8.2% and mortality of 7.3%.
- Jaundice and significantly deranged liver function tests were identified as indicators of a poor prognosis.
Implications:
- Effective treatment strategies for visceral leishmaniasis are available, but vigilance for prognostic indicators is crucial.
- Understanding seasonal patterns and clinical manifestations aids in early diagnosis and management of VL in endemic regions.
- Further research into risk factors for relapse and mortality in pediatric VL is warranted.
Abstract:
Kala-azar (visceral leishmaniasis [VL]) is endemic in southern Iran. We retrospectively evaluated 367 infants and children suffering from VL at hospitals affiliated to the Shiraz University of Medical Sciences in Fars Province, southwest Iran). Seasonal variations were observed with more cases presenting in late winter, spring and fewer in summer. The predominant clinical features in these patients were chronic fever, pallor, weight loss, abdominal distention and hepatosplenomegaly. Lymphadenopathy was less common. Common laboratory abnormalities included anaemia, leukopenia, thrombocytopenia, hypoalbuminaemia and hypergammaglobulinaemia. Liver function tests were deranged in two-thirds of the patients. The immunofluorescence antibody test was positive in all patients and all of them had a positive bone marrow smear or a culture for Leishmania donovani. Patients responded well to glucantim therapy with a cure rate of 96.7%. Relapse was observed in 8.2% (30). Mortality in this series was 7.3%. Twenty patients died during their therapy period. Jaundice and grossly deranged liver function tests were found to be bad prognostic signs.
Related Concept Videos
Leishmaniasis
Antiprotozoal Agents
Fungal Phylum Microsporidia

